Drugs / L.rhamnosus R0011 strain
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07510282 | Apr → Aug 2026 overdue | — | University College Dublin | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07439978 | Apr → Jun 2026 overdue | — | University College Dublin | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L.rhamnosus R0011 strain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07439978 ↗ |
| Modality | Other / unclassified | “probiotic bacteria” NCT07439978 ↗ |
| Route | Oral | “28-day ingestion of a yoghurt beverage with and without the probiotic strain of interest” NCT07510282 ↗ |